| Literature DB >> 28676033 |
Maryam Poormontaseri1, Saeid Hosseinzadeh2, Seyed Shahram Shekarforoush1, Tahereh Kalantari3.
Abstract
BACKGROUND: Some Bacillus strains have recently been identified for potential use as probiotics and food additives. The present study evaluated the antimicrobial effects of Bacillus subtilis ATCC 6633 and its metabolite on the enterotoxin and vegetative cells, spore and germinated spore of Clostridium perfringens type A in Caco-2 cells.Entities:
Keywords: Bacillus Subtilis; Caco-2 cell line; Clostridium perfringens; Cytotoxicity; Flow cytometry
Mesh:
Year: 2017 PMID: 28676033 PMCID: PMC5496268 DOI: 10.1186/s12866-017-1051-1
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Polacrylamide gel electrophoresis of enterotoxin (50 μg) following gel filtration chromatography on Sephadex G-200. Lane 1: Protein marker (10 KDa), Lane 2: Purified CPE following chromatography
Fig. 2Minimal inhibitory concentration (MIC) of crude antimicrobial substance (CAS) against vegetative, spore and germinated spore of C. perfringens type A. Bars represented SD values of triplicates. Symbol (*) on the bars of each concentration representing significant differences (P < 0.05)
Different experimental groups used in this study
| Experimental groups | Treatments |
|---|---|
| 1 | Crude antimicrobial substance (CAS) 8% |
| 2 | CAS 4% |
| 3 |
|
| 4 | Vegetative form of |
| 5 | Spore form of |
| 6 | Germinated spore form of |
| 7 |
|
| 8 | CPE+ |
| 9 | CPE+ CAS 4% |
| 10 | Vegetative form of |
| 11 | Vegetative form of |
| 12 | Spore form of |
| 13 | Spore form of |
| 14 | Germinated spore form of |
| 15 | Germinated spore form of |
Percent of the cytotoxicity of B. subtilis strains, crude antimicrobial substance (CAS) and different forms of C. perfringens in Caco-2 cells
| Experimental groups | Cytotoxicity (%) |
|---|---|
| 1 | 32.09 ± 1.84a |
| 2 | 6.1425 ± 0.82b |
| 3 | 18.1375 ± 1.36c |
| 4 | 46.3675 ± 1.52d |
| 5 | 52.67 ± 1.75e |
| 6 | 65.0425 ± 1.80f |
| 7 | 94.9525 ± 2.91g |
Values are mean SD of five replications. Different letters are represented the statistical difference (P< 0.05). Treatments are described in Table 1.
The survival rates (%) of Caco-2 cells treated with various experimental groups using MTT and flow cytometry assays
| Experimental groups | Cells survival (%) | |
|---|---|---|
| MTT assay | Flow cytometry assay | |
| Negative control | 97.79 ± 2.3a | |
| 2 | 95.16 ± 3.59aA | 95.32 ± 2.77bA |
| 3 | 86.56 ± 3.69bA | 92.71 ± 2.77cB |
| 4 | 56.02 ± 1.8dA | 61.42 ± 1.21eB |
| 5 | 51.59 ± 1.71eA | 57.65 ± 0.83fB |
| 6 | 37.66 ± 2fA | 42.29 ± 0.85gB |
| 7 | 7.05 ± 0.41cA | 13.08 ± 0.71dB |
| 8 | 12.74 ± 0.73gA | 18.74 ± 2.07hB |
| 9 | 10.94 ± 0.57gA | 16.32 ± 1.1jB |
| 10 | 65.55 ± 1.75iA | 71.66 ± 1.69kB |
| 11 | 78 ± 2.67kA | 85.42 ± 0.87mB |
| 12 | 59.85 ± 2.58lA | 67.45 ± 2.05nB |
| 13 | 72.42 ± 2.39jA | 78.33 ± 1.89lB |
| 14 | 44.83 ± 1.67mA | 50.05 ± 1.74oB |
| 15 | 51.58 ± 1.67e | 59.40 ± 1.37q |
Values are mean ± SD of five and three replications for MTT and flow cytometry assays, respectively. Different small and capital letters are representing the statistical difference between each column and rows, respectively (P < 0.05). Treatments are described in Table 1.
Fig. 3Percent of apoptotic and necrotic effects on the Caco-2 cells treated with B. subtilis ATCC 6633 or PY79 stains and different forms of C. perfringens using flow cytometry assay. Bars represented SD values of triplicates. Different small and capital letters on the bars, representing significant differences for apoptotic and necrotic cells, respectively (P < 0.05). Groups are described in Table 1